We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
-5.89%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$266M
AUM Growth
-$65.2M
Cap. Flow
-$10.3M
Cap. Flow %
-3.88%
Top 10 Hldgs %
77.45%
Holding
39
New
3
Increased
16
Reduced
10
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$10.5M
3
MDCO
Medicines Co
MDCO
+$8.91M
4
USO icon
United States Oil Fund
USO
+$7.45M
5
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$4.31M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$10.4M
2
ACHN
Achillion Pharmaceuticals
ACHN
+$10.2M
3
INCY icon
Incyte
INCY
+$10.2M
4
ARWR icon
Arrowhead Research
ARWR
+$8.21M
5
HRTX icon
Heron Therapeutics
HRTX
+$6.66M

Sector Composition

Rank Sector Weight
1 Healthcare 89.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMBR
26
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$476K 0.18%
85
+38
+81% +$194K
GBT
27
DELISTED
Global Blood Therapeutics, Inc.
GBT
$375K 0.14%
25,963
-69,751
-73% -$1.23M
NTRA icon
28
Natera
NTRA
$38.7B
$371K 0.14%
31,693
– –
BOLD
29
DELISTED
Audentes Therapeutics, Inc
BOLD
$365K 0.14%
20,000
– –
MNKD icon
30
PUT
MannKind Corp
MNKD
$1.17B
$279K 0.11%
87,700
+86,823
+9,900% +$251K
SRTSW
31
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$78K 0.03%
+155,000
New +$142K
ALPN
32
DELISTED
Alpine Immune Sciences Inc
ALPN
$67K 0.03%
7,500
– –
ABEO icon
33
Abeona Therapeutics
ABEO
$364M
– –
-776
Closed -$116K
ARWR icon
34
Arrowhead Research
ARWR
$12.1B
– –
-1,116,777
Closed -$8.21M
GLD icon
35
SPDR Gold Trust
GLD
$131B
– –
-83,000
Closed -$10.4M
HRTX icon
36
Heron Therapeutics
HRTX
$96.8M
– –
-386,787
Closed -$6.66M
NVAX icon
37
CALL
Novavax
NVAX
$1.22B
– –
-239
Closed -$996K
FPRX
38
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-44,044
Closed -$2.31M
JO
39
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
– –
-180,500
Closed -$4.02M
1
2

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

RTW Investments's Q4 2016 Portfolio in Review

As of Q4 2016, RTW Investments held 39 positions worth $266M, down 20% from $331M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

RTW Investments withdrew a net $10.3M in Q4 2016, closing 7 positions and reducing 10 holdings. Its most notable exit was SPDR Gold Trust, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 90% a quarter earlier.

Against the trend, RTW Investments opened a new position in PTC Therapeutics worth $10.9M.

  • RTW Investments's largest Q4 2016 buy was PTC Therapeutics: 997,166 shares worth $10.9M.
  • RTW Investments added most to Bristol-Myers Squibb in Q4 2016, an estimated $19.5M increase.
  • RTW Investments's biggest Q4 2016 reduction was Achillion Pharmaceuticals, cutting an estimated $10.2M.
  • RTW Investments fully exited SPDR Gold Trust in Q4 2016, selling an estimated $10.4M.
  • RTW Investments's ten largest holdings make up 77% of its $266M portfolio in Q4 2016.
  • RTW Investments opened 3 new positions and closed 7 in Q4 2016.
  • RTW Investments's portfolio value fell 20% quarter-over-quarter to $266M.

Based on RTW Investments's 13F filing for Q4 2016, filed 15 Feb 2017.